Cargando…
The evaluation of β-adrenoceptor blocking agents in patients with COPD and congestive heart failure: a nationwide study
OBJECTIVE: β-Blockers are safe and improve survival in patients with both congestive heart failure (CHF) and COPD. However, the superiority of different types of β-blockers is still unclear among patients with CHF and COPD. The association between β-blockers and CHF exacerbation as well as COPD exac...
Autores principales: | Liao, Kuang-Ming, Lin, Tien-Yu, Huang, Yaw-Bin, Kuo, Chen-Chun, Chen, Chung-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584777/ https://www.ncbi.nlm.nih.gov/pubmed/28894360 http://dx.doi.org/10.2147/COPD.S141694 |
Ejemplares similares
-
Cardiac and Vascular α(1)-Adrenoceptors in Congestive Heart Failure: A Systematic Review
por: Kaykı-Mutlu, Gizem, et al.
Publicado: (2020) -
Adrenal adrenoceptors in heart failure
por: de Lucia, Claudio, et al.
Publicado: (2014) -
Epidemiological profile and obstetric outcomes of patients with peripartum congestive heart failure in Taiwan: a retrospective nationwide study
por: Chang, Ying-Jen, et al.
Publicado: (2017) -
Congestive heart failure
por: Zhao, Xuan
Publicado: (2019) -
Serum Positive for the Autoantibody against the β
(1)-Adrenoceptor from Chinese Patients with Congestive Heart Failure Decreases I
(ss) in Mouse Cardiac Myocytes
por: Wang, Yuan-yuan, et al.
Publicado: (2011)